LSB

LakeShore Biopharma
LSB

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

LSB was delisted on the 19th of September, 2025.

Back to rankings

9 hedge funds and large institutions have $1.02M invested in LakeShore Biopharma in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$43K
2
+$25.6K
3
+$686
4
UBS Group
UBS Group
Switzerland
+$147

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$344K
Fidelity Investments
2
Fidelity Investments
Massachusetts
$282K
HA
3
HHLR Advisors
Cayman Islands
$182K
SCM
4
Superstring Capital Management
New York
$74.5K
Barclays
5
Barclays
United Kingdom
$61K
Toronto Dominion Bank
6
Toronto Dominion Bank
Ontario, Canada
$43K
Citadel Advisors
7
Citadel Advisors
Florida
$25.6K
UBS Group
8
UBS Group
Switzerland
$2.45K
TRCT
9
Tower Research Capital (TRC)
New York
$686